Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Avacta Life Sciences Ltd
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
NextPoint Therapeutics, Inc.
Xencor, Inc.
Tempest Therapeutics
Ludwig Institute for Cancer Research
Pfizer
Merrimack Pharmaceuticals
Corcept Therapeutics